Niche Companies are Being Overlooked by Investors

Investors are losing on potential gains by choosing style over substance
NEW YORK - May 29, 2014 - PRLog -- Let’s face it, joint pain may be a growing concern amongst aging baby boomers however, as an investment it’s boring. Wound care even more so. Yet, niche companies targeting these monotonous segments are taking advantage of health care trends and many investors are missing out due to the appeal of companies developing the next cancer “breakthrough” that doesn’t materialize.

Horizon Pharma (HZNP) has grown nearly 500% in price during the last year. This “boring” company is flying under the radar. With the recent acquisition of Vidar, the company will continue it's growing trend meaning investors can still benefit.

Using similar growth tactics as Horizon, Alliqua (ALQA) is a niche wound care player that should not be overlooked by investors making the same mistake. Alliqua is ramping up an acquisition strategy that is expected to deliver robust top line growth and as a result lead to price appreciation.

To find out more about these rather "boring", but lucrative companies:

Email:*** Email Verified
Tags:Stock Picks, Newsletter, Small-cap, Top Stocks, Investment
Industry:Banking, Biotech
Location:New York City - New York - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
LastFinancier PRs
Trending News
Top Daily News
Top Weekly News

Like PRLog?
Click to Share